Picture of Procter & Gamble Health logo

PGHL Procter & Gamble Health Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeMid CapHigh Flyer

Annual income statement for Procter & Gamble Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
2025
March 31st
Period Length:12 M12 M12 M12 M9 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue10,08711,14412,29611,5139,342
Cost of Revenue
Gross Profit6,6086,8887,8247,4256,167
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses7,9238,7339,3308,9296,325
Operating Profit2,1642,4112,9662,5843,017
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes2,3332,5343,1422,7333,116
Provision for Income Taxes
Net Income After Taxes1,7681,9252,2952,0102,344
Net Income Before Extraordinary Items
Net Income1,7681,9252,2952,0102,344
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income1,7681,9252,2952,0102,344
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS107119143131142
Dividends per Share
Special Dividends per Share